Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 407

Results For "MS"

5470 News Found

ProBioGen  and ValenzaBio enter second service agreement
Biotech | June 15, 2022

ProBioGen and ValenzaBio enter second service agreement

The new program includes upstream and downstream process development and large-scale GMP production.


Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
Supply Chain | June 15, 2022

Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions

Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals


Philips announces positive research results from its TOBA II BTK clinical trial
Clinical Trials | June 14, 2022

Philips announces positive research results from its TOBA II BTK clinical trial

First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial


Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’
Healthcare | June 12, 2022

Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’

India’s first oncology laboratory for comprehensive Cancer Diagnostic services


Alembic receives USFDA tentative approval for Dasatinib tablets
Drug Approval | June 12, 2022

Alembic receives USFDA tentative approval for Dasatinib tablets

Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive


Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis
Clinical Trials | June 12, 2022

Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis

Amarex Clinical Research guides its client to phase II of FDA trials


China NMPA approves Tislelizumab for metastatic nasopharyngeal cancer
Drug Approval | June 12, 2022

China NMPA approves Tislelizumab for metastatic nasopharyngeal cancer

Tislelizumab is now approved in nine indications in China


Modi Inaugurates hospital complex and CoE in South Gujarat
Public Health | June 11, 2022

Modi Inaugurates hospital complex and CoE in South Gujarat

Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools


Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries
Clinical Trials | June 11, 2022

Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries

New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets